These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 38775725)
1. Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet. Lewandowski SL; El K; Campbell JE Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E103-E110. PubMed ID: 38775725 [TBL] [Abstract][Full Text] [Related]
2. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. Yabe D; Seino Y Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006 [TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041 [TBL] [Abstract][Full Text] [Related]
7. Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both? Yabe D; Seino Y; Seino Y J Diabetes Investig; 2018 Jan; 9(1):21-24. PubMed ID: 28746743 [TBL] [Abstract][Full Text] [Related]
8. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism. Vahl T; D'Alessio D Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Pathak V; Vasu S; Flatt PR; Irwin N Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718 [TBL] [Abstract][Full Text] [Related]
11. Incretin actions beyond the pancreas: lessons from knockout mice. Yabe D; Seino Y Curr Opin Pharmacol; 2013 Dec; 13(6):946-53. PubMed ID: 24095602 [TBL] [Abstract][Full Text] [Related]
12. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice. Sridhar A; Khan D; Babu G; Irwin N; Gault VA; Flatt PR; Moffett CR Peptides; 2024 Aug; 178():171254. PubMed ID: 38815655 [TBL] [Abstract][Full Text] [Related]
13. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957 [TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves. Mayer F; Gunawan AL; Tso P; Aponte GW Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 and control of insulin secretion. Thorens B Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147 [TBL] [Abstract][Full Text] [Related]
17. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034 [TBL] [Abstract][Full Text] [Related]
18. Patients With Long-QT Syndrome Caused by Impaired Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848 [TBL] [Abstract][Full Text] [Related]
19. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Gault VA; Kerr BD; Harriott P; Flatt PR Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446 [TBL] [Abstract][Full Text] [Related]